Insiders Recursion Pharmaceuticals, Inc.

Equities

RXRX

US75629V1044

Market Closed - Nasdaq Other stock markets 01:30:00 11/05/2024 am IST			5-day change	1st Jan Change
8.6 ^USD	-0.46%		-2.71%	-12.78%

10/05	Recursion Pharmaceuticals Q1 Loss Widens, Revenue Rises	MT
09/05	Earnings Flash (RXRX) RECURSION PHARMACEUTICALS Reports Q1 Revenue $13.8M, vs. Street Est of $12.7M	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Recursion Pharmaceuticals Insider Sold Shares Worth $367,007, According to a Recent SEC Filing	19/04	MT
Recursion Pharmaceuticals Names Najat Khan Chief R&D Officer	17/04	MT
Recursion Appoints Najat Khan as Chief R&D Officer and Chief Commercial Officer	16/04	CI
Recursion Pharmaceuticals Insider Sold Shares Worth $537,190, According to a Recent SEC Filing	15/03	MT
Recursion Pharmaceuticals, Inc. Appoints Kristen Rushton as Chief Business Operations Officer	28/02	CI
Recursion Pharmaceuticals Insider Sold Shares Worth $507,985, According to a Recent SEC Filing	16/02	MT
Recursion Pharmaceuticals Insider Sold Shares Worth $444,981, According to a Recent SEC Filing	10/02	MT
Recursion Pharmaceuticals, Inc. Announces Transition of Shafique Virani from the Chief Business Officer into Senior Strategic Advisor	08/02	CI
Recursion Pharmaceuticals Insider Sold Shares Worth $517,508, According to a Recent SEC Filing	19/01	MT
Recursion Pharmaceuticals Insider Sold Shares Worth $396,214, According to a Recent SEC Filing	12/01	MT
Recursion Pharmaceuticals Insider Sold Shares Worth $273,202, According to a Recent SEC Filing	12/01	MT
Recursion Pharmaceuticals Insider Sold Shares Worth $374,638, According to a Recent SEC Filing	15/12	MT
Recursion Pharmaceuticals Insider Sold Shares Worth $448,394, According to a Recent SEC Filing	09/12	MT
Recursion Pharmaceuticals Insider Sold Shares Worth $117,180, According to a Recent SEC Filing	18/11	MT
Recursion Pharmaceuticals Insider Sold Shares Worth $340,929, According to a Recent SEC Filing	17/11	MT
Recursion Pharmaceuticals Insider Sold Shares Worth $321,301, According to a Recent SEC Filing	06/11	MT
Recursion Pharmaceuticals Insider Sold Shares Worth $348,075, According to a Recent SEC Filing	13/23/13	MT
Recursion Pharmaceuticals Insider Sold Shares Worth $431,025, According to a Recent SEC Filing	09/23/09	MT
Recursion Pharmaceuticals Insider Sold Shares Worth $155,880, According to a Recent SEC Filing	20/23/20	MT
Insider Sell: Recursion Pharmaceuticals	09/23/09	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Recursion Pharmaceuticals, Inc.

Equities

RXRX

US75629V1044

Insiders

Filters